Qepler | summits & conferences | 2nd Annual Highly Potent APIs Summit, Pregue, 19-21 February 2020
Event Location:
Prague, Czech Republic
Venue:
Novotel Praha Wenceslas Square Hotel Katerinska 1476/38
Date:
19 February 2020 - 21 February 2020
Language:
English

Early Bird discounts:
Register early to save € 300 for the Individual ticket, € 400 per person for 2-3 Delegates, € 600 per person for 4+ delegates from the same company until 15 December 2019.

Conference Overview

The increasing incidence of cancer and the ever-rising demand for anticancer drugs results in significant growth for the highly potent active pharmaceutical ingredients (HPAPIs) market. The highly toxic properties of HPAPIs, however, present manufacturing and handling challenges. Our meeting facilitates hands-on experience sharing with focus on early process development and scale up, occupational health regulations and safety standards, cross-contamination risk assessment and control, aseptic facilities and equipment maintenance and cleaning, outsourcing and technology transfer strategies.

The featured talks on:

  • EMA and GMP guidelines: novel requirements and considerations
  • Staying compliant with occupational HSE regulations and policies
  • Best practice containment strategies for highly potent APIs
  • Utilizing quality risk management practices to HPAPIs production
  • Handling and optimizing early process development
  • Understanding and developing a robust scale-up process
  • Handling highly potent compounds for ADC generation
  • Design and cleaning considerations for manufacturing facilities
  • Selecting the right CDMO partner for HPAPIs project
  • Successful technology transfer and outsourcing strategies

Meet our Speakers

Our Sponsors

Silver Sponsor
ILC Dover is a world leader in the innovative design and manufacturer of engineered products employing high-performance flexible materials to aerospace, medical and inflatables markets.
ILC Dover
Bronze Sponsor
Lonza is one of the world's leading suppliers to the Pharma&Biotech and Specialty Ingredient markets with products that enhance your overall quality of life.
Lonza AG

PREVIOUS EVENT

SNAPSHOT OF ATTENDEES

Affygility Solutions - Ardena - ARTeSYN Biosolutions - Bayer AG - Bayer Consumer Care AG - Biocon - Bristol Myers Squibb - Celgene - ChargePoint Technology Ltd - EVER Pharma Jena GmbH - Gedeon Richter - GlaxoSmithKline - Guido Maik Consulting - Hebeler Process Solution LLC - HPAPI Project Services Limited - ILC Dover - Ipsen - JLS International Germany - Krka, d.d., Novo mesto - Leeds Beckett University - Lonza - Lonza Pharma & Biotech - Lusochimica SpA - Merck Group - Minaken - Mitsui & Co. Italia S.P.A. - MSD - Novartis - Novasep - Oriento SA - Patheon, part of Thermo Fisher Scientific - Piramal Pharma Solutions - Pliva Croatia Ltd, TAPI Croatia - Praevena AG - Regeneron Pharmaceuticals, Inc - Skan AG - Takeda Ireland Limited - Umicore AG & Co KG - Others